Atypical Femur Fractures (AFF) are associated with Bisphosphonate Osteoporosis Therapy. Bisphosphonate therapy is widely used as the Gold-Standard Therapy for Osteoporosis: it increases bone density and reduce the risk of vertebral, non-vertebral and hip fractures. However, long-term alendronic acid administration can causes severely suppressed bone turnover and finally non-traumatic stress fractures. Here we present a case of Non-Traumatic stress fractures of bilateral femoral shafts in a Long-Term Alendronic Acid Therapy.
Atypical Bilateral Femur Fractures in a Long-Term Bisphosphonate Therapy: A Case Report
VALENTINI, ROBERTO;MOGHNIE, ALESSANDRO;SCAMACCA, VERONICA;MARTINO, MARCELLINO;PERIN, SILVIA;MURENA, LUIGI
2015-01-01
Abstract
Atypical Femur Fractures (AFF) are associated with Bisphosphonate Osteoporosis Therapy. Bisphosphonate therapy is widely used as the Gold-Standard Therapy for Osteoporosis: it increases bone density and reduce the risk of vertebral, non-vertebral and hip fractures. However, long-term alendronic acid administration can causes severely suppressed bone turnover and finally non-traumatic stress fractures. Here we present a case of Non-Traumatic stress fractures of bilateral femoral shafts in a Long-Term Alendronic Acid Therapy.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
atypical-bilateral-femur-fractures-in-a-longterm-bisphosphonate-therapy-a-case-report-2161-0533-1000189.pdf
accesso aperto
Descrizione: pdf editoriale
Tipologia:
Documento in Versione Editoriale
Licenza:
Digital Rights Management non definito
Dimensione
1.46 MB
Formato
Adobe PDF
|
1.46 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.